PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company’s successful implementation of an effective quality management system.
NEW YORK, N.Y., Feb. 26, 2016 (SEND2PRESS NEWSWIRE) — Long-time environmental activist Erin Brockovich is joining with Weitz and Luxenberg, P.C., attorney Robin Greenwald to investigate claims from Portland, Oregon area residents who may have been harmed by chemical emissions released into the air by art-glass companies in the region.
PORTLAND, Ore., Jan. 7, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016 Healthcare Conference, being held in San Francisco, January 11-14. The conference, which is now in its 34th year, is an invitation-only event intended to create an […]
CANBY, Ore., Nov. 17, 2015 (SEND2PRESS NEWSWIRE) — Dr. Craig Wagner Shinn announces that his great grandfather Dr. Edward Reed Wagner, a missionary doctor in the American Board of Commissioners of Foreign Missions (Global Ministries) in the late 19th century, was honored for founding Huamei Hospital in Linqing, Shandong, China at a special ceremony celebrating […]
PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug. CE mark approval is recognized and associated […]
PORTLAND, Ore., Oct. 16, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives. On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly […]
PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.
PORTLAND, Ore., June 25, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug.
PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.
PORTLAND, Ore., April 9, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.
PORTLAND, Ore., Nov. 8, 2013 (SEND2PRESS NEWSWIRE) — Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products […]
PORTLAND, Ore., Oct. 9, 2013 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast(R) range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.
PORTLAND, Ore. /CitizenWire/ — Evolve Security, an IP-focused security distributor based in Portland, Oregon, today announced a distribution partnership with Smartvue, a leading manufacturer of IP video surveillance solutions.
PORTLAND, Ore. /CitizenWire/ — ClanGistics(TM) announces the launch of their ClanGistics.com website which includes a first time ever e-product called the ClanGistics Planning System(TM). The planning system utilizes secured "cloud" server technology and data file encryption allowing users to login through a secured web portal and enter personal information safely and securely for instant access […]
EUGENE, Ore. /CitizenWire/ — Hearthside Food Solutions, LLC, one of the country's leading manufacturers of all natural cereal and granola products, has recently introduced another "on trend" variety of delicious granola under its GT Classic brand: Baobab Coconut Granola, made with organic (MWO) ingredients. Baobab, heralded by Organics Processing Magazine as one of 2011's top […]
EUGENE, Ore. (CitizenWire) — Noble Vision Group, LLC, a research and development organization, today announced the success of its first LIVE Webcast broadcast by SoundQue Multimedia Services, a unique multimedia production facility that specializes in video and audio streaming.
